| Science communication reconsidered T Bubela, MC Nisbet, R Borchelt, F Brunger, C Critchley, E Einsiedel, ... Nature biotechnology 27 (6), 514-518, 2009 | 658 | 2009 |
| Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine D Lau, U Ogbogu, B Taylor, T Stafinski, D Menon, T Caulfield Cell stem cell 3 (6), 591-594, 2008 | 374 | 2008 |
| ISSCR guidelines for stem cell research and clinical translation: the 2021 update R Lovell-Badge, E Anthony, RA Barker, T Bubela, AH Brivanlou, ... Stem cell reports 16 (6), 1398-1408, 2021 | 245 | 2021 |
| A review of the key issues associated with the commercialization of biobanks T Caulfield, S Burningham, Y Joly, Z Master, M Shabani, P Borry, ... Journal of Law and the Biosciences 1 (1), 94-110, 2014 | 153 | 2014 |
| Virtual care: Enhancing access or harming care? L Hardcastle, U Ogbogu Healthcare management forum 33 (6), 288-292, 2020 | 120 | 2020 |
| The commercialization of university-based research: Balancing risks and benefits T Caulfield, U Ogbogu BMC medical ethics 16, 1-7, 2015 | 115 | 2015 |
| Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better? U Ogbogu, C Rachul, T Caulfield Regenerative medicine 8 (3), 361-369, 2013 | 90 | 2013 |
| iPS cells: mapping the policy issues A Zarzeczny, C Scott, I Hyun, J Bennett, J Chandler, S Chargé, H Heine, ... Cell 139 (6), 1032-1037, 2009 | 86 | 2009 |
| Health misinformation and the power of narrative messaging in the public sphere T Caulfield, AR Marcon, B Murdoch, JM Brown, ST Perrault, J Jarry, ... Canadian Journal of Bioethics 2 (2), 52-60, 2019 | 85 | 2019 |
| The stem cell research environment: a patchwork of patchworks T Caulfield, A Zarzeczny, J McCormick, T Bubela, C Critchley, E Einsiedel, ... Stem Cell Reviews and Reports 5, 82-88, 2009 | 51 | 2009 |
| Informed consent in embryonic stem cell research: are we following basic principles? T Caulfield, U Ogbogu, RM Isasi CMAJ 176 (12), 1722-1725, 2007 | 50 | 2007 |
| Research ethics and stem cells: Is it time to re‐think current approaches to oversight? T Caulfield, K Kamenova, U Ogbogu, A Zarzeczny, J Baltz, S Benjaminy, ... EMBO reports 16 (1), 2-6, 2015 | 38 | 2015 |
| Non-invasive prenatal testing and the unveiling of an impaired translation process B Murdoch, V Ravitsky, U Ogbogu, S Ali-Khan, G Bertier, S Birko, ... Journal of Obstetrics and Gynaecology Canada 39 (1), 10-17, 2017 | 34 | 2017 |
| Professional regulation: a potentially valuable tool in responding to “stem cell tourism” A Zarzeczny, T Caulfield, U Ogbogu, P Bell, VA Crooks, K Kamenova, ... Stem Cell Reports 3 (3), 379-384, 2014 | 34 | 2014 |
| Promoting ethical payment in human infection challenge studies HF Lynch, TC Darton, J Levy, F McCormick, U Ogbogu, RO Payne, ... The American Journal of Bioethics 21 (3), 11-31, 2021 | 33 | 2021 |
| The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions U Ogbogu, J Du, Y Koukio BMC medical ethics 19, 1-6, 2018 | 29 | 2018 |
| Stem cell research ethics: consensus statement on emerging issues T Caulfield, U Ogbogu, E Nelson, E Einsiedel, B Knoppers, M McDonald, ... Journal of Obstetrics and Gynaecology Canada 29 (10), 843-848, 2007 | 29 | 2007 |
| The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials M Yarborough, A Bredenoord, F D’Abramo, NC Joyce, J Kimmelman, ... PLoS biology 16 (6), e2006343, 2018 | 28 | 2018 |
| Promotion and marketing of bioidentical hormone therapy on the internet: a content analysis of websites N Yuksel, L Treseng, B Malik, U Ogbogu Menopause 24 (10), 1129-1135, 2017 | 24 | 2017 |
| Patents, commercialization and the Canadian stem cell research community T Caulfield, U Ogbogu, C Murdoch, E Einsiedel Regenerative Medicine 3 (4), 483-496, 2008 | 24 | 2008 |
Timothy CaulfieldProfessor, Faculty of Law and School of Public Health, University of AlbertaVerified email at ualberta.ca
